ATE337315T1 - Verfahren zur herstellung von naphthyridin carbonsäure derivaten (methansulfonat sesquihydrat) - Google Patents

Verfahren zur herstellung von naphthyridin carbonsäure derivaten (methansulfonat sesquihydrat)

Info

Publication number
ATE337315T1
ATE337315T1 AT99950532T AT99950532T ATE337315T1 AT E337315 T1 ATE337315 T1 AT E337315T1 AT 99950532 T AT99950532 T AT 99950532T AT 99950532 T AT99950532 T AT 99950532T AT E337315 T1 ATE337315 T1 AT E337315T1
Authority
AT
Austria
Prior art keywords
naphthyridine
producing
acid derivatives
methanesulfonate sesquihydrate
carboxic acid
Prior art date
Application number
AT99950532T
Other languages
English (en)
Inventor
Jerome Francis Hayes
Timothy Charles Walsgrove
Andrew Stephen Wells
Original Assignee
Lg Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Life Sciences Ltd filed Critical Lg Life Sciences Ltd
Application granted granted Critical
Publication of ATE337315T1 publication Critical patent/ATE337315T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
AT99950532T 1998-09-18 1999-09-15 Verfahren zur herstellung von naphthyridin carbonsäure derivaten (methansulfonat sesquihydrat) ATE337315T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9820405.0A GB9820405D0 (en) 1998-09-18 1998-09-18 Process

Publications (1)

Publication Number Publication Date
ATE337315T1 true ATE337315T1 (de) 2006-09-15

Family

ID=10839123

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99950532T ATE337315T1 (de) 1998-09-18 1999-09-15 Verfahren zur herstellung von naphthyridin carbonsäure derivaten (methansulfonat sesquihydrat)

Country Status (25)

Country Link
US (1) US6818771B1 (de)
EP (1) EP1114050B1 (de)
JP (1) JP2002526498A (de)
KR (1) KR100679062B1 (de)
CN (1) CN1315825C (de)
AT (1) ATE337315T1 (de)
AU (1) AU751060B2 (de)
BR (1) BR9913858A (de)
CA (1) CA2344439C (de)
CY (1) CY1106171T1 (de)
CZ (1) CZ297509B6 (de)
DE (1) DE69932938T8 (de)
DK (1) DK1114050T3 (de)
ES (1) ES2272084T3 (de)
GB (1) GB9820405D0 (de)
HK (1) HK1038557A1 (de)
HU (1) HU227068B1 (de)
IL (2) IL141933A0 (de)
NO (1) NO317997B1 (de)
NZ (1) NZ510590A (de)
PL (1) PL194707B1 (de)
PT (1) PT1114050E (de)
TR (1) TR200100797T2 (de)
WO (1) WO2000017199A1 (de)
ZA (1) ZA200102160B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA24500A1 (fr) 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
US20020032216A1 (en) 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
CA2281817C (en) * 1999-06-29 2008-07-29 Smithkline Beecham Corporation Methods of use of fluoroquinolone compounds against maxillary sinus pathogenic bacteria
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
KR20010091379A (ko) * 2000-03-15 2001-10-23 성재갑 7-(4-아미노메틸-3-옥심)피롤리딘 치환체를 갖는 퀴놀린카르복실산 유도체의 신규 제조방법
EP1412078B1 (de) 2001-08-02 2008-10-08 LG Life Sciences Limited Verfahren zur herstellung von amino-geschützten 4-aminomethylene-pyrrolidin-3-on-derivaten, gemifloxacin und deren salze
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
WO2006044903A1 (en) * 2004-10-18 2006-04-27 Neurocrine Biosciences, Inc. HYDRATE OF N-METHYL-N-(3-{3-[2-THIENYLCARBONYL]-PYRAZOL-[1,5-α]- PYRAMIDIN-7-YL}PHENYL)ACETAMIDE AND PROCESSES AND METHODS RELATED THERETO
EP2161270A1 (de) * 2005-06-15 2010-03-10 Hetero Drugs Limited Gemifloxacinhydrate

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57134482A (en) 1981-02-13 1982-08-19 Dainippon Pharmaceut Co Ltd 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation
JPH0356479A (ja) 1989-07-24 1991-03-12 Takeshi Yokota 水溶性キノロン誘導体のp‐トルエンスルホン酸塩
WO1991002526A1 (en) * 1989-08-16 1991-03-07 Pfizer Inc. Azabicyclo quinolone carboxylic acids
DK0688772T3 (da) 1994-06-16 1999-11-01 Lg Chemical Ltd Quinolincarboxylsyrederivater med 7-(4-aminomethyl-3-oxim)-pyrrolidinsubstituenter og fremgangsmåde til deres fremstilling
US5776944A (en) * 1994-06-16 1998-07-07 Lg Chemical Ltd. 7-(4-aminomethyl-3-methyloxyiminopyrroplidin-1-yl)-1-cyclopropyl-6-flu oro-4-oxo-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid and the process for the preparation thereof
JP3449658B2 (ja) 1994-12-21 2003-09-22 杏林製薬株式会社 安定性に優れた8−アルコキシキノロンカルボン酸水和物並びにその製造方法
DK0789697T3 (da) * 1995-06-06 1998-10-19 Pfizer Krystalform af vandfrit 7-([1alfa, 5alfa, 6alfa,]-6-amino-3-azabicyclo[3.1.0]hex-3-yl)-6-fluor-1-(2,4-difluorphenyl)-1,4-d
UA59341C2 (uk) 1995-08-11 2003-09-15 Пфайзер, Інк. (1s,2s)-1-(4-гідроксифеніл)-2-(4-гідрокси-4-фенілпіперидин-1-іл)-1-пропанолметансульфонат тригідрат
UA49880C2 (uk) * 1996-03-29 2002-10-15 Смітклайн Бічам Корпорейшн Дигідрат ерпоcартану, фармацевтична композиція, спосіб отримання твердої дозованої форми, спосіб блокування рецепторів ангіотензину іі
MA24500A1 (fr) * 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
US20020032216A1 (en) 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
KR100286874B1 (ko) 1998-03-04 2001-04-16 성재갑 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법
US6127400A (en) 1998-05-29 2000-10-03 Pharmacia & Upjohn Company Salts of diamine pyrrolidine

Also Published As

Publication number Publication date
IL141933A0 (en) 2002-03-10
HK1038557A1 (en) 2002-03-22
JP2002526498A (ja) 2002-08-20
HUP0103914A3 (en) 2002-05-28
WO2000017199A1 (en) 2000-03-30
ES2272084T3 (es) 2007-04-16
AU6328399A (en) 2000-04-10
EP1114050A1 (de) 2001-07-11
NZ510590A (en) 2003-05-30
TR200100797T2 (tr) 2001-10-22
KR20010075160A (ko) 2001-08-09
DE69932938T2 (de) 2007-03-15
DE69932938T8 (de) 2007-07-12
DE69932938D1 (de) 2006-10-05
NO20011290L (no) 2001-03-14
CY1106171T1 (el) 2011-06-08
CA2344439A1 (en) 2000-03-30
NO317997B1 (no) 2005-01-17
CZ297509B6 (cs) 2007-01-03
HUP0103914A2 (hu) 2002-03-28
PL346656A1 (en) 2002-02-25
US6818771B1 (en) 2004-11-16
PL194707B1 (pl) 2007-06-29
PT1114050E (pt) 2006-12-29
CN1315825C (zh) 2007-05-16
NO20011290D0 (no) 2001-03-14
BR9913858A (pt) 2001-06-12
GB9820405D0 (en) 1998-11-11
CZ2001978A3 (cs) 2002-01-16
DK1114050T3 (da) 2006-10-09
CN1318066A (zh) 2001-10-17
ZA200102160B (en) 2002-06-26
AU751060B2 (en) 2002-08-08
CA2344439C (en) 2010-05-11
IL141933A (en) 2009-02-11
KR100679062B1 (ko) 2007-02-05
EP1114050B1 (de) 2006-08-23
HU227068B1 (hu) 2010-06-28

Similar Documents

Publication Publication Date Title
DE69625712T2 (de) Verfahren zur herstellung von tetrahydroimidazochinolinaminen
DE69632207D1 (de) Verfahren zur herstellung von imidazochinolinaminen
DE60006298D1 (de) Verfahren zur Herstellung von Kohlendioxid
DE69506462D1 (de) Verfahren zur Herstellung von aromatischer Carbonsäure
DE69608834T2 (de) Verfahren zur Herstellung einer Carbonsäure
DE69902846D1 (de) Verfahren zur Herstellung von aromatischen Carbonsäuren
ATE337315T1 (de) Verfahren zur herstellung von naphthyridin carbonsäure derivaten (methansulfonat sesquihydrat)
DE69809357T2 (de) Verfahren zur Herstellung von aromatischer Carbonsäure
DE60009807D1 (de) Verfahren zur herstellung von (-)pyridobenzoxazin-carbonsäure-derivaten
DE69931493D1 (de) Verfahren zur herstellung von hydroxymethylthiobuttersäure
MY125309A (en) Process for production of naphthyridine-3-carboxylic acid derivatives
DE60007734D1 (de) Verfahren zur herstellung von wasserfreier gabapentin von pharmazeutischer qualität
DE60105314D1 (de) Verfahren zur herstellung von taxanderivaten
ATE238303T1 (de) Verfahren zur herstellung von 2-phenyl-imidazo(1, 2-a)pyridine-3-acetamiden
MY126789A (en) Intermediates for the production of quinoline carboxylic acid derivatives
DE60012337D1 (de) Verfahren zur herstellung von fluorcarbonsäureanyhydriden
DE60003807D1 (de) Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung
ATE234288T1 (de) Verfahren zur herstellung eines buthylthuio- isochinolinderivates und zwischenprodukte dafür
DE69502580D1 (de) Verfahren zur Herstellung aromatischer Carbonsäuren
DE59807664D1 (de) Verfahren zur herstellung von 3-cyano-2,4-dihalogen-5-fluor-benzoesäuren
DE59205377D1 (de) Mikrobiologisches Verfahren zur Herstellung von 5-Hydroxypyrazincarbonsäure
ATE342254T1 (de) Verfahren zur herstellung von derivaten von [(1,5-diaryl)pyrazol-3-ylöpropansäure
DE69409776T2 (de) Verfahren zur Herstellung Pyridin-2,3-dicarboxylicsäure
ATE297478T1 (de) Verfahren zur herstellung von orthocarbonsäuretrialkylestern
DE60034699D1 (de) Verfahren zur herstellung von fumagillin

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1114050

Country of ref document: EP